F1000Research · 2018 · 11 citations · 64 references
MedicineGeneticsOncologyEpigeneticsEpigenomicsPediatric OncologyCancer EpigeneticsCancer EpigenomicsCancer GenomicsEpigenetic Regulation In CancerPediatric Cancer GeneticsPediatric LeukemiasAcute LeukemiasEpigenetic ControlEpigenetic StratificationEpigenetic TherapiesEpigenomic AlterationsMicrorna EpigeneticsMicrorna-mediated Epigenetic ControlTherapeutic Epigenetics
Pediatric leukemia represents a heterogeneous group of diseases characterized by germline and somatic mutations that manifest within the context of disturbances in the epigenetic machinery and genetic regulation. Advances in genomic medicine have allowed finer resolution of genetic and epigenetic strategies that can be effectively used to risk-stratify patients and identify novel targets for therapy. This review discusses the genetic and epigenetic mechanisms of leukemogenesis, particularly as it relates to acute lymphocytic leukemias, the mechanisms of epigenetic control of leukemogenesis, namely DNA methylation, histone modifications, microRNAs, and LINE-1 retroelements, and highlights opportunities for precision medicine therapeutics in further guiding disease management. Future efforts to broaden the integration of advances in genomic and epigenomic science into the practice of pediatric oncology will not only identify novel therapeutic strategies to improve clinical outcomes but also improve the quality of life for this unique patient population. Recent findings in precision therapeutics of acute lymphocytic leukemias over the past three years, along with some provocative areas of epigenetics research, are reviewed here.
64
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Stephen Rea, Frank Eisenhaber, Dónal O’Carroll et al. · Nature · 2000 · 2.8K citations
Childhood and adolescent cancer statistics, 2014
Elizabeth Ward, Carol DeSantis, Anthony Robbins et al. · CA A Cancer Journal for Clinicians · 2014 · 2.4K citations · Full text
Medicine, Oncology, Pediatrics +14
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
Charles G. Mullighan, Xiaoping Su, Jinghui Zhang et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text
Life Sciences, Genetics, Hematology +15
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
Kathryn G. Roberts, Yongjin Li, Debbie Payne-Turner et al. · New England Journal of Medicine · 2014 · 1.4K citations · Full text
Life Sciences, Genetics, Oncology +17